body{--wpr-bg-a4190d05-ef47-40e6-8ee1-91bc26b98d0d: url('https://dailystar.com.lb/wp-content/themes/sahifa/images/patterns/body-bg7.png');}code{--wpr-bg-6f189767-0d74-4bc0-9401-442e86dcb97a: url('https://dailystar.com.lb/wp-content/themes/sahifa/images/code-bg.png');}.ilightbox-loader.dark div{--wpr-bg-bb00a55a-f9db-4fac-9843-7464e0b4d431: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/preloader.gif');}.ilightbox-holder.dark .ilightbox-container .ilightbox-caption{--wpr-bg-aca680a6-0778-45c1-bf58-bedc43f31f6e: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/caption-bg.png');}.ilightbox-holder.dark .ilightbox-container .ilightbox-social{--wpr-bg-e2491487-bc65-493b-8a8e-0b80355682df: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/caption-bg.png');}.ilightbox-holder.dark .ilightbox-alert{--wpr-bg-1c6aa03d-b158-4f4e-9776-b249c59ffbc4: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/alert.png');}.ilightbox-toolbar.dark a{--wpr-bg-a6321233-62c4-4077-b0dd-44a530de5868: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/buttons.png');}.ilightbox-thumbnails.dark .ilightbox-thumbnails-grid .ilightbox-thumbnail .ilightbox-thumbnail-video{--wpr-bg-3b25c981-ce60-46b6-9f33-b4ac6532cd86: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/thumb-overlay-play.png');}#main-nav ul li.menu-item-home a{--wpr-bg-a033df8e-c8fc-4277-98e8-7564f77f3140: url('https://dailystar.com.lb/wp-content/themes/sahifa/images/home@2x.png');}#main-nav ul li.menu-item-home a{--wpr-bg-b2e3f49b-b900-40c9-9836-12a4cb1d33e9: url('https://dailystar.com.lb/wp-content/themes/sahifa/images/home.png');}.isMobile .ilightbox-toolbar.dark a.ilightbox-fullscreen{--wpr-bg-dd2b397a-c2dd-471e-8a7e-8f40469c8b1e: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/fullscreen-icon-64.png');}.isMobile .ilightbox-toolbar.dark a.ilightbox-next-button{--wpr-bg-3d2e5161-3bd7-407e-8f50-6486dc42a979: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/arrow-next-icon-64.png');}.isMobile .ilightbox-toolbar.dark a.ilightbox-prev-button{--wpr-bg-2f1f68c8-10b8-4aad-b4e5-0d1b679df2dc: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/arrow-prev-icon-64.png');}.isMobile .ilightbox-toolbar.dark a.ilightbox-play{--wpr-bg-a05355ff-e6e2-4107-b634-4ce1a7eb410b: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/play-icon-64.png');}.isMobile .ilightbox-toolbar.dark a.ilightbox-pause{--wpr-bg-2ca36a76-d3a3-4ba1-a318-98b90b782ae1: url('https://dailystar.com.lb/wp-content/themes/sahifa/css/ilightbox/dark-skin/pause-icon-64.png');}.rll-youtube-player .play{--wpr-bg-aa2d6488-94bd-422f-8a2c-8307d968b3d5: url('https://dailystar.com.lb/wp-content/plugins/wp-rocket/assets/img/youtube.png');}

The Daily Star Lebanon Breaking News, Lebanon News, Middle East News & World News

Tag Archives: mRNA technology

Russian cancer vaccine Enteromix shows 100% efficacy, set for rollout

September 7, 2025 0

Breakthrough mRNA Cancer Vaccine Shows 100% Success in Trials In what could mark a major milestone in cancer treatment, Russian researchers have developed an mRNA-based vaccine that has shown 100% safety and efficacy during clinical trials. Known as Enteromix, the vaccine demonstrated the ability to shrink large tumors and, in some cases, destroy them entirely. According to Russia Today (RT), …